- Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
-
Woo HY, Park JY, Bae SH, Kim CW, Jang JY, Tak WY, Kim DJ, Kim IH, Heo J, Ahn SH
- KMID: 2504510
- Clin Mol Hepatol.
- 2020 Jul;26(3):352-363.
- doi: 10.3350/cmh.2019.0044n
Background/Aims: Suboptimal responses to lamivudine or telbivudine plus adefovir (LAM/LdT+ADV) rescue therapy are common in patients with LAM-resistant hepatitis B virus (HBV) infections. We compared patients switched to entecavir plus... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
-
Lee SK, Jang JW, Nam H, Sung PS, Bae SH, Choi JY, Yoon SK
- KMID: 2505847
- J Liver Cancer.
- 2020 Mar;20(1):84-89.
- doi: 10.17998/jlc.20.1.84
The efficacy and safety of sequential systemic therapy for the treatment of recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) are not well established. This study describes a successful experience... -
- CITED
-
- Close
- SHARE
-
- Close
- Upregulation of C-Reactive Protein by Placenta-Derived Mesenchymal Stem Cells Promotes Angiogenesis in A Rat Model with Cirrhotic Liver
-
Jun JH, Jung J, Kim JY, Hwang SG, Bae SH, Kim GJ
- KMID: 2508914
- Int J Stem Cells.
- 2020 Nov;13(3):404-413.
- doi: 10.15283/ijsc20052
Background and Objectives: Liver cirrhosis is accompanied by abnormal vascular shunts. The Wnt pathway is essential for endothelial cell survival and proliferation. C-reactive protein (CRP), which is produced by hepatocyte,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms
-
Lee J, Sung PS, Eom KS, Yang H, Lee SK, Bwa AH, Lozada A, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 2501320
- Clin Mol Hepatol.
- 2020 Jan;26(1):78-82.
- doi: 10.3350/cmh.2019.0078
-
- CITED
-
- Close
- SHARE
-
- Close
- Early Onset Polymorphic Post-transplant Lymphoproliferative Disease Mimicking a Solitary Necrotizing Abscess in a Graft Liver
-
Sung PS, Lee J, Lee J, Nam HC, Bae SH, Yoon SK
- KMID: 2463619
- J Liver Cancer.
- 2019 Sep;19(2):165-170.
- doi: 10.17998/jlc.19.2.165
Although post-transplantation lymphoproliferative disease (PTLD) after liver transplantation is very rare, its prognosis is worse than that of PTLD following other types of solid organ transplantation. Here, we report a... -
- CITED
-
- Close
- SHARE
-
- Close
- Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling
-
Sung PS, Lee EB, Park DJ, Lozada A, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 2428758
- Clin Mol Hepatol.
- 2018 Sep;24(3):302-310.
- doi: 10.3350/cmh.2017.0074
BACKGROUND/AIMS: Hepatitis C virus (HCV) replicates in the peripheral blood mononuclear cells (PBMCs), leading to the production of type I interferons (IFNs). It is well known that the gene expression... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Central Bile Duct Invasion Causing Conjugated Hyperbilirubinemia: Safety and Prognostic Factors for Survival
-
Yang K, Sung PS, Oh JS, Chun HJ, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 2422624
- J Liver Cancer.
- 2018 Sep;18(2):121-129.
- doi: 10.17998/jlc.18.2.121
BACKGROUND/AIMS: The treatments and outcomes of hepatocellular carcinoma (HCC) with bile duct invasion are not well known. We aimed to confirm the safety of transarterial chemolipiodolization (TACL) and identify prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcome of donor biliary complications following living donor liver transplantation
-
Woo HY, Lee IS, Chang JH, Youn SB, Bae SH, Choi JY, Chun HJ, You YK, Kim DG, Yoon SK
- KMID: 2415997
- Korean J Intern Med.
- 2018 Jul;33(4):705-715.
- doi: 10.3904/kjim.2017.264
BACKGROUND/AIMS: Biliary complications are the most common donor complication following living donor liver transplantation (LDLT). The aim of this study is to investigate the long-term outcomes of biliary complications in... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
-
Seo KI, Bae SH, Sung PS, Park CH, Lee HL, Kim HY, Kim HJ, Jang BH, Jang JW, Yoon SK, Choi JY, Park IY, Lee J, Lee HS, Kim SJ, Kwon JH, Chang UI, Kim CW, Jo SH, Lee Y, Tekle F, Kim JH
- KMID: 2433302
- Clin Mol Hepatol.
- 2018 Dec;24(4):374-383.
- doi: 10.3350/cmh.2017.0082
BACKGROUND/AIMS: There have been numerous efforts to reduce mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with antiviral agents during pregnancy. However, there are limited data regarding the outcomes of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcome of 1,000 consecutive cases of liver transplantation: a single center experience
-
Kwak BJ, Kim DG, Han JH, Choi HJ, Bae SH, You YK, Choi JY, Yoon SK
- KMID: 2422936
- Ann Surg Treat Res.
- 2018 Nov;95(5):267-277.
- doi: 10.4174/astr.2018.95.5.267
PURPOSE: The aim of this study was to analyze survival outcomes in 1,000 consecutive liver transplantations (LTs) performed at a single institution from 1993 to April 2017. METHODS: The study population... -
- CITED
-
- Close
- SHARE
-
- Close
- Difference in F-18 FDG Uptake After Esophagogastroduodenoscopy and Colonoscopy in Healthy Sedated Subjects
-
Oh JR, Seo JH, Chang WJ, Bae SI, Song IW, Bong JG, Jeong HY, Park SY, Bae J, Yoon H
- KMID: 2396582
- Nucl Med Mol Imaging.
- 2017 Sep;51(3):240-246.
- doi: 10.1007/s13139-016-0460-7
PURPOSE: We aimed to evaluate the difference in fluorodeoxyglucose (FDG) uptake in sedated healthy subjects after they underwent esophagogastroduodenoscopy (EGD) and colonoscopy procedures. METHODS: The endoscopy group (n = 29) included... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
-
Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK
- KMID: 2413116
- Clin Mol Hepatol.
- 2017 Jun;23(2):128-137.
- doi: 10.3350/cmh.2016.0071
BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS)... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of bronchiolitis obliterans organizing pneumonia during standard treatment of hepatitis C with Peg-IFNα2b
-
Chung E, Park K, Kim JH, Han NI, Lee YS, Bae SH, Park CH
- KMID: 2396771
- Korean J Intern Med.
- 2017 Nov;32(6):1098-1100.
- doi: 10.3904/kjim.2013.124
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy
-
Lee HL, Bae SH, Jang B, Hwang S, Yang H, Nam HC, Sung PS, Lee SW, Jang JW, Choi JY, Han NI, Song BJ, Lee JW, Yoon SK
- KMID: 2395393
- Gut Liver.
- 2017 Nov;11(6):870-877.
- doi: 10.5009/gnl16434
BACKGROUND/AIMS: According to the results of several studies, the outcome of hepatitis C virus (HCV) reactivation is not as severe as the outcome of hepatitis B virus reactivation. The aim... -
- CITED
-
- Close
- SHARE
-
- Close
- Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation
-
Jun JH, Choi JH, Bae SH, Oh SH, Kim GJ
- KMID: 2373138
- Clin Mol Hepatol.
- 2016 Sep;22(3):372-381.
- doi: 10.3350/cmh.2016.0032
BACKGROUND/AIMS: Chronic liver disease leads to liver fibrosis, and although the liver does have a certain regenerative capacity, this disease is associated with dysfunction of the liver vessels. C-reactive protein... -
- CITED
-
- Close
- SHARE
-
- Close
- High-level Expression of Interleukin-17 and C-reactive Protein Predicts Tumor Progression in Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization
-
Song MJ, Lee SW, Oh EJ, Jang B, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 2357340
- J Liver Cancer.
- 2016 Sep;16(2):108-117.
- doi: 10.17998/jlc.2016.16.2.108
BACKGROUND/AIMS: Transarterial chemoembolization (TACE) is the standard locoregional treatment in patients with unresectable hepatocellular carcinoma (HCC). Angiogenesis and inflammation play important roles in tumor growth in HCC. In this study,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Ulcerative Colitis Following Acute Hepatitis Induced by Epstein-Barr Virus Infection
-
Oh SH, You CR, Kim EO, Bae SH, Choi JY, Yoon SK, Choi SW
- KMID: 2350088
- Korean J Gastroenterol.
- 2016 Aug;68(2):104-108.
- doi: 10.4166/kjg.2016.68.2.104
Epstein-Barr virus (EBV) infection varies in its clinical manifestations and severity. EBV can be a causative agent of hepatitis and may have a role in the pathogenesis of chronic autoimmune... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
-
Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK
- KMID: 2373799
- Korean J Intern Med.
- 2016 Mar;31(2):242-252.
- doi: 10.3904/kjim.2015.112
BACKGROUND/AIMS: We compared the recurrence of hepatocellular carcinoma (HCC) and the survival of patients who received radiofrequency ablation (RFA) after transarterial chemoembolization (TACE) with patients treated with TACE or RFA... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Complete Response by Multidisciplinary Management in a Patient with Solitary Bone Metastasis after Curative Resection of Hepatocellular Carcinoma
-
Hwang S, Yang H, Lee HL, Jang JW, Bae SH, Choi JY, Yoon SK
- KMID: 2198524
- J Liver Cancer.
- 2016 Mar;16(1):52-56.
- doi: 10.17998/jlc.2016.16.1.52
Despite recent advances in the treatment of hepatocellular carcinoma (HCC), the prognosis of patients with extrahepatic metastasis from HCC still remains dismal. The current study presents a case of HCC... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatments Other than Sorafenib for Patients with Advanced Hepatocellular Carcinoma
-
Song DS, Bae SH
- KMID: 2198515
- J Liver Cancer.
- 2016 Mar;16(1):1-6.
- doi: 10.17998/jlc.2016.16.1.1
Sorafenib is the standard treatment for advanced hepatocellular carcinoma according to the Barcelona Clinic Liver Cancer staging system. However, because of its unsatisfactory efficacy, adverse effects, and high cost, the... -
- CITED
-
- Close
- SHARE
-
- Close
